Kexing Biopharm Obtained IND Approval for Its Self-developed GB05 from U.S. FDA

SHENZHEN,China,Feb. 14,2025-- Kexing Biopharm Co.,Ltd. (Stock Code: 688136.SH) recently announced that the Investigational New Drug Application (IND) of GB05,Human Interferon α1b Inhalation Solution,

OneConnect Integrates DeepSeek into AI Agent Platform

SHANGHAI,Feb. 13,2025-- OneConnect Financial Technology Co.,Ltd ("OneConnect" or the "Company",NYSE: OCFT,HKSE: 6638),a business technology service provider for financial instituti

Beyond Pouch Packaging: Hanmi Pharmaceutical Introduces a New Automated Vial Dispensing Solution in Canada and the United States

Hanmi Pharmaceutical Global Business Headquarters Accelerates Expansion into Canadian and US Markets,Strengthening Collaboration with Distribution Partner McKesson

Bellevue Life Sciences Acquisition Corp. Announces Approval of Business Combination Proposal And Name Change to OSR Holdings, Inc.

SEOUL,South Korea,Feb. 14,2025-- Bellevue Life Sciences Acquisition Corp. ("BLAC") announced today the approval of each of the proposals presented at the special meeting of its stockholders

Saudi Ministry of Finance and IMF Prepare to Launch AlUla Conference for Emerging Market Economies

RIYADH,Saudi Arabia,Feb. 14,2025-- The AlUla Conference for Emerging Market Economies,organized jointly by the Saudi Ministry of Finance and the International Monetary Fund (IMF),kicks off next week

Polyplastics Launches New Eco-friendly PLASTRON (R) ︎LFT with Reduced Weight, Higher Rigidity, and Strong Damping

TOKYO,Feb. 13,2025-- Polyplastics Co.,Ltd.,a global leader in engineering plastics,has launched PLASTRON (R) LFT (long fiber-reinforced thermoplastic) RA627P,an eco-friendly composite of polypropylene

Webull Masters 2025 Kicks Off: an Exciting Stock Trading Competition in Thailand with Over THB170,000 in Prizes

BANGKOK,Feb. 13,2025-- Webull Securities (Thailand) Co. Ltd. ("Webull Thailand"),the Thai subsidiary of Webull Corporation ("Webull"),a leading global digital investment platform,

Antengene Announces XPOVIO® Approved for Public Health Insurance Coverage in Taiwan Market, Benefiting More Patients with R/R MM in the Region

XPOVIO® is the first XPO1 inhibitor approved in Taiwan for the treatment of adult patients with relapsed/refractory multiple myeloma (R/R MM).

Akeso Announces IND Acceptance for AK139, a Bispecific Antibody Targeting IL-4Rα and ST2 for Respiratory and Skin Diseases

HONG KONG,Feb. 14,2025-- Akeso,Inc. (9926. HK) ("Akeso" or the "Company") is pleased to announce the acceptance of its Investigational New Drug (IND) application by the China Natio

HERO ESPORTS Asian Champions League Honor of Kings Tournament Announces $200,000 Prize Pool, Champions will Secure Spot at Esports World Cup

Champion of the HERO ESPORTS Asian Champions League Honor of Kings tournament will secure a spot at the Esports World Cup